• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Functional exhaustion of antiviral lymphocytes in COVID-19 patients.

作者信息

Zheng Meijuan, Gao Yong, Wang Gang, Song Guobin, Liu Siyu, Sun Dandan, Xu Yuanhong, Tian Zhigang

机构信息

Department of Clinical Laboratory, First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Department of Clinical Laboratory, Fuyang Second People's Hospital, Fuyang Infectious Disease Clinical College, Anhui Medical University, Fuyang, Anhui, China.

出版信息

Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2. Epub 2020 Mar 19.

DOI:10.1038/s41423-020-0402-2
PMID:32203188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7091858/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/7193576/d1e0cb0b2c72/41423_2020_402_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/7193576/d1e0cb0b2c72/41423_2020_402_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4f2/7193576/d1e0cb0b2c72/41423_2020_402_Fig1_HTML.jpg

相似文献

1
Functional exhaustion of antiviral lymphocytes in COVID-19 patients.新冠病毒肺炎患者抗病毒淋巴细胞的功能耗竭
Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2. Epub 2020 Mar 19.
2
NKG2A and COVID-19: another brick in the wall.自然杀伤细胞2A（NKG2A）与新型冠状病毒肺炎（COVID-19）：拼图中的另一块拼图。
Cell Mol Immunol. 2020 Jun;17(6):672-674. doi: 10.1038/s41423-020-0450-7. Epub 2020 May 7.
3
Antiviral Drug Discovery To Address the COVID-19 Pandemic.抗病毒药物研发应对 COVID-19 大流行。
mBio. 2020 Sep 25;11(5):e02134-20. doi: 10.1128/mBio.02134-20.
4
Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.使用多梳蛋白抑制剂作为抗病毒药物靶向严重急性呼吸综合征冠状病毒2（SARS-CoV-2）
Epigenomics. 2020 May;12(10):811-812. doi: 10.2217/epi-2020-0154. Epub 2020 Jun 4.
5
The impact of COVID-19 on hepatitis elimination.2019冠状病毒病对消除肝炎的影响。
Lancet Gastroenterol Hepatol. 2020 Sep;5(9):792-794. doi: 10.1016/S2468-1253(20)30238-7. Epub 2020 Jul 27.
6
Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.基因伊甸-VIR和诺维林对严重急性呼吸综合征冠状病毒的作用：对2019冠状病毒病的启示。
J Evid Based Integr Med. 2020 Jan-Dec;25:2515690X20932523. doi: 10.1177/2515690X20932523.
7
Baricitinib for COVID-19: a suitable treatment?巴瑞替尼用于治疗新冠肺炎：一种合适的治疗方法？
Lancet Infect Dis. 2020 Sep;20(9):1012-1013. doi: 10.1016/S1473-3099(20)30262-0. Epub 2020 Apr 3.
8
COVID-19 and viral hepatitis elimination programs: Are we stepping backward?2019冠状病毒病与消除病毒性肝炎计划：我们在倒退吗？
Liver Int. 2020 Aug;40(8):2042. doi: 10.1111/liv.14486. Epub 2020 May 25.
9
Use of antiviral drugs to reduce COVID-19 transmission.使用抗病毒药物减少新冠病毒传播。
Lancet Glob Health. 2020 May;8(5):e639-e640. doi: 10.1016/S2214-109X(20)30114-5. Epub 2020 Mar 19.
10
Baricitinib for COVID-19: a suitable treatment? - Authors' reply.巴瑞替尼用于治疗新冠肺炎：一种合适的治疗方法？——作者回复
Lancet Infect Dis. 2020 Sep;20(9):1013-1014. doi: 10.1016/S1473-3099(20)30270-X. Epub 2020 Apr 3.

引用本文的文献

1
Mathematical modelling of the heterogeneity of disease progression and treatment outcomes in patients with COVID-19.新型冠状病毒肺炎患者疾病进展和治疗结果异质性的数学建模
Front Microbiol. 2025 Jul 28;16:1551320. doi: 10.3389/fmicb.2025.1551320. eCollection 2025.
2
NK Cells: A Powerful Squad Versus SARS-CoV-2.自然杀伤细胞：对抗新冠病毒的强大力量
Int J Mol Sci. 2025 Jul 6;26(13):6500. doi: 10.3390/ijms26136500.
3
Investigation of -21 M/T Dimorphism and Its Potential Role in COVID-19.-21 M/T 二态性及其在 COVID-19 中的潜在作用研究。
Int J Mol Sci. 2025 Jul 3;26(13):6419. doi: 10.3390/ijms26136419.
4
Discovery and development of a safe and efficient COVID-19 mRNA vaccine, STP2104, using a novel capping library screening method.利用新型帽结构文库筛选方法发现并开发一种安全有效的新冠病毒mRNA疫苗STP2104。
Front Immunol. 2025 Jun 9;16:1571713. doi: 10.3389/fimmu.2025.1571713. eCollection 2025.
5
Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice.人类和ACE2人源化小鼠对SARS-CoV-2感染的免疫反应。
Fundam Res. 2021 Mar;1(2):124-130. doi: 10.1016/j.fmre.2021.03.001. Epub 2021 Mar 3.
6
Low-Dose naltrexone restored TRPM3 ion channel function in natural killer cells from long COVID patients.低剂量纳曲酮恢复了长新冠患者自然杀伤细胞中的TRPM3离子通道功能。
Front Mol Biosci. 2025 May 19;12:1582967. doi: 10.3389/fmolb.2025.1582967. eCollection 2025.
7
Optimized tacrolimus dosing strategy in kidney transplant recipients receiving nirmatrelvir-ritonavir for COVID-19.接受用于治疗COVID-19的奈玛特韦-利托那韦的肾移植受者的他克莫司优化给药策略
PLoS One. 2025 May 30;20(5):e0309875. doi: 10.1371/journal.pone.0309875. eCollection 2025.
8
Cytoimmunological Profile of Lower Airways in Post-COVID-19 Syndrome (PCS): Predictive Value of Bronchoalveolar Lavage.新冠后综合征（PCS）下呼吸道的细胞免疫特征：支气管肺泡灌洗的预测价值
J Clin Med. 2025 May 12;14(10):3361. doi: 10.3390/jcm14103361.
9
Aging-associated changes in immunological parameters: Implications for COVID-19 immune response in the elderly.免疫参数的衰老相关变化：对老年人COVID-19免疫反应的影响。
Physiol Rep. 2025 May;13(10):e70364. doi: 10.14814/phy2.70364.
10
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19.与严重新型冠状病毒肺炎风险降低相关的高亲和力CD16A基因多态性
JCI Insight. 2025 May 22;10(13). doi: 10.1172/jci.insight.191314. eCollection 2025 Jul 8.